CHRM3 and central nervous system cancer: In view of the discovery of CHRM3-AS2/miR-370-5p/KLF4 axis in glioma cells, we suspected that CHRM3-AS2 silencing may exert inhibitory effects on glioma cells through regulating miR-370-5p/KLF4.